FindTrial
Sign In

A scientific study to assess prevalence of metabolic syndrome (MetS) in the cisgender-heterosexual, cisgender-sexual minority, transgender-heterosexual, and transgender-sexual minority subjects.

Epidemiological, cross-sectional study to assess prevalence of metabolic syndrome (MetS) in the cisgender-heterosexual, cisgender-sexual minority, transgender-heterosexual and transgender-sexual minority subjects.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/031843
Enrollment
1536
Registered
2021-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Rajiv Kovil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals who are able and willing to give written informed consent 2. Individuals must be aged >=18 years at the time of screening 3. Individuals who are willing to identify their gender identity and sexual orientation 4. Individuals who are willing and able to comply with scheduled visits, laboratory tests and other study procedures

Exclusion criteria

Exclusion criteria: 1. Individuals who are unwilling to complete a survey 2. Individuals unwilling to follow the study requirements 3. Individuals who are on pharmacotherapy for individual components of MetS 4. Pregnant and lactating individuals

Design outcomes

Primary

MeasureTime frame
To find the prevalence of MetS and itâ??s componentsTimepoint: Single Visit—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Rajiv Kovil

Zandra Healthcare Private Limited

rajivrkovil@gmail.com02226287242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026